You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

primary systemic amyloidosis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Light Chain Deposition Disease, Primary Systemic Amyloidosis Trial in Canada, United States (pomalidomide, bortezomib,

Active, not recruiting
  • Light Chain Deposition Disease
  • Primary Systemic Amyloidosis
  • Denver, Colorado
  • +4 more
Jan 20, 2023

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
Has Results
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

Screening for Systemic Amyloidosis Via the Ligamentum Flavum

Completed
  • Amyloid
  • +4 more
  • Biopsy
  • Cleveland, Ohio
    Cleveland Clinic
Dec 21, 2021

Primary Systemic Amyloidosis Trial in Milwaukee (Doxycycline)

Completed
Has Results
  • Primary Systemic Amyloidosis
  • Milwaukee, Wisconsin
    Froedtert & Medical College of Wisconsin
Jun 18, 2021

Amyloidosis Trial in Athens (Lenalidomide, Dexamethasone and Cyclophosphamide)

Completed
  • Amyloidosis
  • Lenalidomide, Dexamethasone and Cyclophosphamide
  • Athens, Attica, Greece
    Alexandra Hospital , Department of Clinical Therapeutics
Apr 27, 2021

Amyloidosis, Light Chain (AL) Amyloidosis Trial (Bendamustine Hydrochloride, Isatuximab)

Withdrawn
  • Amyloidosis
  • Light Chain (AL) Amyloidosis
  • (no location specified)
Dec 29, 2022

Light Chain Amyloidosis Trial (FKC288)

Not yet recruiting
  • Light Chain Amyloidosis
  • (no location specified)
Jul 30, 2023

Amyloidosis, Primary, Cardiomyopathy Trial in Boston (F-18 florbetapir/C-11 acetate PET, MRI, N-13 ammonia PET)

Recruiting
  • Amyloidosis, Primary
  • Cardiomyopathy
  • F-18 florbetapir/C-11 acetate PET
  • +2 more
  • Boston, Massachusetts
    Brigham and Womens' Hospital
Oct 23, 2022

Amyloidosis; Systemic Trial in Woolloongabba, Box Hill (AT02)

Not yet recruiting
  • Amyloidosis; Systemic
  • Woolloongabba, Queensland, Australia
  • +1 more
Jul 11, 2023

Amyloidosis, Transthyretin Amyloidosis Trial in Portland (124I-Evuzamitide)

Recruiting
  • Amyloidosis
  • Transthyretin Amyloidosis
  • 124I-Evuzamitide
  • Portland, Oregon
    Oregon Health & Science University
Feb 24, 2023

AL Amyloidosis, Light Chain (AL) Amyloidosis, Systemic Light Chain Disease Trial in San Francisco (Venetoclax, Dexamethasone,

Not yet recruiting
  • AL Amyloidosis
  • +2 more
  • San Francisco, California
    University of California, San Francisco
Aug 16, 2022

Systemic Transthyretin Amyloidosis: Carpal Tunnel Syndrome

Recruiting
  • Transthyretin Amyloidosis
  • Carpal Tunnel Syndrome
  • Synovial biopsy and Cardiac scintigraphy with [99mTc]Tc-DPD
  • Porto, Portugal
    Centro Hospitalar Universitário São João
Jan 12, 2023

Systemic Amyloidosis Trial in Knoxville (99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.,

Recruiting
  • Systemic Amyloidosis
  • 99mTc-p5+14 is an amyloid reactive peptide labeled with technetium-99m.
  • 99mTc-Pyrophosphate and 99mtc-p5+14 - an Amyloid Reactive Peptide Labeled With Technetium-99m.
  • Knoxville, Tennessee
    University of Tennessee Graduate School of Medicine
Jul 10, 2023

Light Chain (AL) Amyloidosis Trial in New York (STI-6129)

Recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • Duarte, California
  • +3 more
Jan 12, 2023

Light Chain (AL) Amyloidosis Trial (STI-6129)

Not yet recruiting
  • Light Chain (AL) Amyloidosis
  • STI-6129
  • (no location specified)
Jan 11, 2023

Multiple Myeloma Trial in Boston (filgrastim, melphalan, autologous peripheral blood stem cell transplantation)

Completed
  • Multiple Myeloma
  • Boston, Massachusetts
    Cancer Research Center at Boston Medical Center
Sep 15, 2020

Systemic Amyloidosis Trial in Knoxville (124I-p5+14 Injection)

Completed
  • Systemic Amyloidosis
  • 124I-p5+14 Injection
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Mar 23, 2022

Amyloidosis Trial in Berkeley, Sacramento, San Jose (I124-AT01 only)

Active, not recruiting
  • Amyloidosis
  • I124-AT01 only
  • Berkeley, California
  • +2 more
Sep 12, 2022

Amyloidosis; Systemic Trial in Knoxville (124I-AT03)

Recruiting
  • Amyloidosis; Systemic
  • Knoxville, Tennessee
    University of Tennessee Medical Center
Mar 14, 2022

Amyloidosis; Systemic Trial in Beijing (Daratumumab, Bortezomib, Dexamethasone)

Active, not recruiting
  • Amyloidosis; Systemic
  • Beijing, China
    Peking Union Medical College Hospital
May 9, 2022

Amyloidosis; Systemic Trial in Boston (Propylene Glycol-Free Melphalan Hydrochloride)

Terminated
  • Amyloidosis; Systemic
  • Propylene Glycol-Free Melphalan Hydrochloride
  • Boston, Massachusetts
    Boston Medical Center
Jul 1, 2022

Systemic Amyloidosis Trial in Knoxville (Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01))

Active, not recruiting
  • Systemic Amyloidosis
  • Injection of peptide p5+14 radiolabeled with iodine-124 (124I-AT-01)
  • Knoxville, Tennessee
    University of Tennessee Graduate School of Medicine
Jul 28, 2023

Outcome of Patients With Systemic AL Amyloidosis in Europe

Completed
  • AL Amyloidosis
    • Wien, Austria
    • +12 more
    Sep 26, 2022

    Arrhythmia Burden in Cardiac Amyloidosis Using Implantable Loop

    Recruiting
    • Arrythmia
    • +3 more
    • LINQ device - implantable cardiac monitor - referred to in the application as "implantable loop recorder" or "ILR")
    • London, United Kingdom
      Royal Free London NHS Foundation Trust
    Sep 29, 2021

    AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

    Not yet recruiting
    • AL Amyloidosis
    • Venetoclax Oral Tablet, 200 mg
    • +9 more
    • New York, New York
      New York Presbyterian Hospital/Columbia University Irving Medica
    Jul 11, 2022